The Saudi Clinical Practice Guideline for the treatment of venous thromboembolism

References

1. ↵
   1. Bates SM,
   2. Jaeschke R,
   3. Stevens SM,
   4. Goodacre S,
   5. Wells PS,
   6. Stevenson MD,
   7. et al.

   (2012) Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e351S–e418S.

   OpenUrlCrossRefPubMedWeb of Science
2. 1. Silverstein MD,
   2. Heit JA,
   3. Mohr DN,
   4. Petterson TM,
   5. O’Fallon WM,
   6. Melton LJ 3rd.

   (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158:585–593.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Anderson FA Jr.,
   2. Wheeler HB,
   3. Goldberg RJ,
   4. Hosmer DW,
   5. Patwardhan NA,
   6. Jovanovic B,
   7. et al.

   (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151:933–938.

   OpenUrlCrossRefPubMedWeb of Science
4. ↵
   1. Goldhaber SZ,
   2. Bounameaux H

   (2012) Pulmonary embolism and deep vein thrombosis. Lancet 379:1835–1846.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Kearon C,
   2. Akl EA,
   3. Comerota AJ,
   4. Prandoni P,
   5. Bounameaux H,
   6. Goldhaber SZ,
   7. et al.

   (2012) Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141(2 Suppl):e419S–e494S.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Yeh CH,
   2. Gross PL,
   3. Weitz JI

   (2014) Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood 124:1020–1028.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Ministry of Health Portal

   (2014) The Saudi Center for Evidence Based Healthcare, Clinical Practice Guideline on the Treatment of Venous Thromboembolism. Available from:http://www.moh.gov.sa/depts/Proofs/Pages/Guidelines.aspx. Updated 2014 August 10, Cited 2015 May 24.
8. ↵
   1. Schunemann H,
   2. Mustafa R,
   3. Brozek J,
   4. Carrasco-Labra A,
   5. Brignardello-Peterson R,
   6. Wiercioch W

   (2014) Saudi Arabian Handbook for Healthcare Guideline Development. Available from:http://www.moh.gov.sa/endepts/Proofs/Pages/GuidelineAdaptation.aspx.
9. ↵
   1. World Health Organization

   (2012) WHO Handbook for Guideline Development (WHO, Geneva (CH)) Available from:http://apps.who.int/iris/bitstream/10665/75146/1/9789241548441_eng.pdf. Cited 2014 February 7.
10. ↵
    1. McMaster University Guideline Working Group

    (2014) Methodology for the Development of the Ministry of Health of Saudi Arabia and McMaster University Clinical Practice Guidelines. Available from:http://www.moh.gov.sa/endepts/Proofs/Pages/GuidelineAdaptation.aspx. Accessed 2015 February 23.
11. ↵
    1. Guyatt G,
    2. Oxman AD,
    3. Akl EA,
    4. Kunz R,
    5. Vist G,
    6. Brozek J,
    7. et al.

    (2011) GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64:383–394.

    OpenUrlCrossRefPubMed
12. ↵
    1. Balshem H,
    2. Helfand M,
    3. Schunemann HJ,
    4. Oxman AD,
    5. Kunz R,
    6. Brozek J,
    7. et al.

    (2011) GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 64:401–406.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    1. Andrews J,
    2. Guyatt G,
    3. Oxman AD,
    4. Alderson P,
    5. Dahm P,
    6. Falck-Ytter Y,
    7. et al.

    (2013) GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol 66:719–725.

    OpenUrlCrossRefPubMed
14. ↵
    1. Othieno R,
    2. Abu Affan M,
    3. Okpo E

    (2007) Home versus in-patient treatment for deep vein thrombosis. Cochrane Database Syst Rev (3):CD003076.
15. ↵
    1. Algahtani F,
    2. Aseri ZA,
    3. Aldiab A,
    4. Aleem A

    (2013) Hospital versus home treatment of deep vein thrombosis in a tertiary care hospital in Saudi Arabia: Are we ready? Saudi Pharm J 21:165–168.

    OpenUrl
16. 1. Levine M,
    2. Gent M,
    3. Hirsh J,
    4. Leclerc J,
    5. Anderson D,
    6. Weitz J,
    7. et al.

    (1996) A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 334:677–681.

    OpenUrlCrossRefPubMedWeb of Science
17. 1. Koopman MM,
    2. Prandoni P,
    3. Piovella F,
    4. Ockelford PA,
    5. Brandjes DP,
    6. van der Meer J,
    7. et al.

    (1996) Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 334:682–687.

    OpenUrlCrossRefPubMedWeb of Science
18. 1. Boccalon H,
    2. Elias A,
    3. Chale JJ,
    4. Cadene A,
    5. Gabriel S

    (2000) Clinical outcome and cost of hospital vs home treatment of proximal deep vein thrombosis with a low-molecular-weight heparin: the Vascular Midi-Pyrenees study. Arch Intern Med 160:1769–1773.

    OpenUrlCrossRefPubMedWeb of Science
19. 1. Ramacciotti E,
    2. Araujo GR,
    3. Lastoria S,
    4. Maffei FH,
    5. Karaoglan de Moura L,
    6. Michaelis W,
    7. et al.

    (2004) An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis. Thromb Res 114:149–153.

    OpenUrlCrossRefPubMed
20. 1. Chong BH,
    2. Brighton TA,
    3. Baker RI,
    4. Thurlow P,
    5. Lee CH,
    6. ASTH DVT Study Group

    (2005) Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis 19:173–181.

    OpenUrlCrossRefPubMedWeb of Science
21. 1. Daskalopoulos ME,
    2. Daskalopoulou SS,
    3. Tzortzis E,
    4. Sfiridis P,
    5. Nikolaou A,
    6. Dimitroulis D,
    7. et al.

    (2005) Long-term treatment of deep venous thrombosis with a low molecular weight heparin (tinzaparin): a prospective randomized trial. Eur J Vasc Endovasc Surg 29:638–650.

    OpenUrlCrossRefPubMed
22. ↵
    1. Backman K,
    2. Carlsson P,
    3. Kentson M,
    4. Hansen S,
    5. Engquist L,
    6. Hallert C

    (2004) Deep venous thrombosis: a new task for primary health care. A randomised economic study of outpatient and inpatient treatment. Scand J Prim Health Care 22:44–49.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    1. O’Brien B,
    2. Levine M,
    3. Willan A,
    4. Goeree R,
    5. Haley S,
    6. Blackhouse G,
    7. et al.

    (1999) Economic evaluation of outpatient treatment with low-molecular-weight heparin for proximal vein thrombosis. Arch Intern Med 159:2298–2304.

    OpenUrlCrossRefPubMedWeb of Science
24. 1. Huse DM,
    2. Cummins G,
    3. Taylor DC,
    4. Russell MW

    (2002) Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Am J Manag Care 8(1 Suppl):S10–S16.

    OpenUrlPubMedWeb of Science
25. 1. Spyropoulos AC,
    2. Hurley JS,
    3. Ciesla GN,
    4. de Lissovoy G

    (2002) Management of acute proximal deep vein thrombosis: pharmacoeconomic evaluation of outpatient treatment with enoxaparin vs inpatient treatment with unfractionated heparin. Chest 122:108–114.

    OpenUrlCrossRefPubMedWeb of Science
26. 1. Tillman DJ,
    2. Charland SL,
    3. Witt DM

    (2000) Effectiveness and economic impact associated with a program for outpatient management of acute deep vein thrombosis in a group model health maintenance organization. Arch Intern Med 160:2926–2932.

    OpenUrlCrossRefPubMedWeb of Science
27. 1. Rodger M,
    2. Bredeson C,
    3. Wells PS,
    4. Beck J,
    5. Kearns B,
    6. Huebsch LB

    (1998) Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis. CMAJ 159:931–938.

    OpenUrlAbstract/FREE Full Text
28. ↵
    1. van den Belt AG,
    2. Bossuyt PM,
    3. Prins MH,
    4. Gallus AS,
    5. Buller HR

    (1998) Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group. Thromb Haemost 79:259–263.

    OpenUrlPubMedWeb of Science
29. ↵
    1. Al eissi Salih,
    2. Hosny G

    (2013) Impact of an out-patient based strategy for the management of acute deep venous thrombosis in Saudi Arabia. European Journal of Internal Medicine 24:e170.

    OpenUrl
30. ↵
    1. Otero R,
    2. Uresandi F,
    3. Jimenez D,
    4. Cabezudo MA,
    5. Oribe M,
    6. Nauffal D,
    7. et al.

    (2010) Home treatment in pulmonary embolism. Thromb Res 126:e1–e5.

    OpenUrlCrossRefPubMedWeb of Science
31. ↵
    1. Aujesky D,
    2. Roy PM,
    3. Verschuren F,
    4. Righini M,
    5. Osterwalder J,
    6. Egloff M,
    7. et al.

    (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41–48.

    OpenUrlCrossRefPubMedWeb of Science
32. ↵
    1. Piran S,
    2. Le Gal G,
    3. Wells PS,
    4. Gandara E,
    5. Righini M,
    6. Rodger MA,
    7. et al.

    (2013) Outpatient treatment of symptomatic pulmonary embolism: a systematic review and meta-analysis. Thromb Res 132:515–519.

    OpenUrlCrossRefPubMed
33. ↵
    1. Uresandi F,
    2. Otero R,
    3. Cayuela A,
    4. Cabezudo MA,
    5. Jimenez D,
    6. Laserna E,
    7. et al.

    (2007) [A clinical prediction rule for identifying short-term risk of adverse events in patients with pulmonary thromboembolism]. Arch Bronconeumol 43:617–622, Spanish.

    OpenUrlPubMedWeb of Science
34. ↵
    1. Jimenez D,
    2. Yusen RD,
    3. Otero R,
    4. Uresandi F,
    5. Nauffal D,
    6. Laserna E,
    7. et al.

    (2007) Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 132:24–30.

    OpenUrlCrossRefPubMedWeb of Science
35. ↵
    1. Grupa Robocza Europejskiego Towarzystw. a Kardiologicznego (ESC) do spraw rozpoznawania i postepowania w ostrej zatorowości płucnej,
    2. Konstantinides S,
    3. Torbicki A,
    4. Agnelli G,
    5. Danchin N,
    6. Fitzmaurice D,
    7. et al.

    (2014) [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. Kardiol Pol 72:997–1053, Polish.

    OpenUrlCrossRefPubMed